RIYADH: The King Faisal Specialist Hospital and Research Centre has been named the Middle East’s most valuable healthcare brand for the fourth consecutive year, with its brand value surpassing SR6.3 billion ($1.7 billion), according to Brand Finance’s 2026 ranking of the Middle East’s top 150 most valuable brands.
KFSHRC also ranked among Saudi Arabia’s top 10 most valuable brands in Brand Finance’s 2026 report of the Kingdom’s top 100 brands, maintaining its position for the third consecutive year in an achievement that reflects the rising institutional value of specialized healthcare and its growing ability to secure a place among the nation’s leading brands across sectors.
According to the report, KFSHRC topped the Middle East’s 10 most valuable healthcare brands, further reinforcing its role as a regional reference in specialized care, research, medical education, and clinical innovation, while underscoring that its brand value is rooted in measurable medical, research, and operational impact.
This recognition builds on a series of major achievements in 2025, including the world’s first fully robotic artificial heart pump transplant, the world’s first dual robotic implantation of ventricular assist devices, and the world’s first robotic liver lobe transplant for a child, according to a press release.
KFSH also launched Saudi Arabia’s first genetic and cellular therapy manufacturing facility in 2025 while reducing emergency department admission wait times by 75 percent, placing it among the top 5 percent of high-capacity academic medical centers globally on this metric.
Together, these milestones demonstrate KFSHRC’s ability to translate medical, research, and operational innovation into measurable gains in care quality, efficiency, and patient experience.
The ranking also reflects KFSHRC’s broader transformation in line with Saudi Vision 2030, which aims to strengthen the Kingdom’s global position in healthcare.
